Chris Bladen

75 Talavera Rd
Sydney, NSW 2109, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy.

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy.

Journal: Frontiers in physiology

Published: November 01, 2022

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels.

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels.

Journal: Frontiers in pharmacology

Published: September 19, 2022

Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.

Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.

Journal: ACS chemical neuroscience

Published: April 20, 2022

A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties.

A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties.

Journal: ACS chemical neuroscience

Published: February 03, 2022

Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro.

Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro.

Journal: Cannabis and cannabinoid research

Published: May 17, 2021

Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro.

Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro.

Journal: British journal of pharmacology

Published: February 15, 2021

Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro.

Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro.

Journal: Neuropharmacology

Published: September 03, 2020

Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.

Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.

Journal: Pharmacology research & perspectives

Published: November 21, 2019

Differential modulation of NMDA and AMPA receptors by cellular prion protein and copper ions.

Differential modulation of NMDA and AMPA receptors by cellular prion protein and copper ions.

Journal: Molecular brain

Published: September 17, 2018

Anticonvulsant mechanisms of piperine, a piperidine alkaloid.

Anticonvulsant mechanisms of piperine, a piperidine alkaloid.

Journal: Channels (Austin, Tex.)

Published: November 07, 2015

Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Journal: Pflugers Archiv : European journal of physiology

Published: June 30, 2015

Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.

Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.

Journal: ACS chemical neuroscience

Published: October 15, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026